没有合适的资源?快使用搜索试试~ 我知道了~
巴克莱-美股-保险行业-二季度美国保险业预览:财险预期表现复杂-71-96页.pdf
需积分: 0 0 下载量 103 浏览量
2023-07-26
11:47:21
上传
评论
收藏 1.9MB PDF 举报
温馨提示
试读
96页
巴克莱-美股-保险行业-二季度美国保险业预览:财险预期表现复杂-71-96页.pdf
资源推荐
资源详情
资源评论
Equity Research
1 July 2019
CORE
Barclays Capital Inc. and/or one of its affiliates does and seeks to do business with
companies covered in its research reports. As a result, investors should be aware that the
firm may have a conflict of interest that could affect the objectivity of this report. Investors
should consider this report as only a single factor in making their investment decision.
PLEASE SEE ANALYST CERTIFICATION(S) AND IMPORTANT DISCLOSURES BEGINNING ON PAGE 90.
Restricted
- Internal
U.S. Insurance
2Q Preview: Expect Mixed P&C
Results, Volatile Life Earnings
Improving Commercial Re/Insurance P&C Pricing, but 2Q Results Hurt by Tornado
Activity. Although P&C market conditions remain favorable, 2Q P&C results are
expected to be negatively impacted by significantly above-average tornado losses; we
accordingly lower our 2Q EPS estimates. Commercial P&C trends are tightening in every
line except workers’ compensation and we expect this favorable trend to persist.
Property catastrophe reinsurance rates for the mid-year Florida renewals have
substantially increased following large hurricane losses and adverse claim development,
in our view. However, this good news already appears mostly priced-in for the
reinsurance stocks including RNR. Meanwhile, personal lines insurers are generating
favorable underlying underwriting results and the focus appears on growth.
Our OW-rated P&C stocks include Berkshire Hathaway (potential for accretive
acquisitions as well as share buybacks), Allstate and Progressive (strong earnings
trends in auto and home insurance), AIG (turnaround opportunity with top-tier
management team), and Chubb (superior global P&C franchise value).
Life Insurers Benefit from Equity Market Gains, but Low Rates a Persistent Headwind.
Life Insurers are likely to benefit from the year-to-date recovery in equity markets.
However, the 10-year Treasury yield has declined to only 2% and the yield curve
remains flat. This means ’20 EPS expectations could face downward pressure, in our
view. Bellwether life insurer valuations remain compressed with a median P/E of 7-8x;
we envision this situation as being unlikely to change the rate environment’s downward
pressure on earnings power. We expect 2Q 19 life insurer median operating EPS to
increase 11% y/y (+6% on a core basis), although the range widely varies. We expect
ATH, VOYA, LNC and EQH to generate among the strongest 2Q core earnings growth.
Meanwhile, MET, PFG and PRU could show y/y declines in 2Q core operating EPS.
Our OW-rated Life Insurance stocks include: PRU has EPS power of $13 based on our
estimates, and its current P/E of 7x looks attractive. Although 2Q results could be noisy,
PRU has delivered consistent results in its annuity, asset management, and international
businesses. UNM should benefit from improving employment trends. Legacy long-term
care exposure is a concern, but we believe this is already discounted in its valuation.
UNM continues to deliver ongoing share buybacks and dividend increases, and is
currently valued at 6x earnings. LNC has delivered solid results in its US-focused
annuity and life insurance businesses along with accretive acquisitions. The company
has a robust share buyback program and group insurance results are recovering. LNC’s
current valuation of 6x earnings has upside potential, in our view.
EARNINGS PREVIEW
U.S. Insurance/Life
NEUTRAL
Unchanged
U.S. Insurance/Non-Life
NEUTRAL
Unchanged
For a full list of our ratings, price target and
earnings changes in this report, please see
table on page 2.
U.S. Insurance/Non-Life
Jay Gelb, CFA
+1 212 526 1561
jay.gelb@barclays.com
BCI, US
John Dunigan
+1 212 526 2607
john.dunigan2@barclays.com
BCI, US
U.S. Consumer Finance
Mark C. DeVries
+1 212 526 9484
mark.devries@barclays.com
BCI, US
Barclays | U.S. Insurance
1 July 2019 2
Summary of our Ratings, Price Targets and Earnings Changes in this Report (all changes are shown in bold)
Company
Rating
Price
Price Target
EPS FY1 (E)
EPS FY2 (E)
Old
New
28-Jun-19
Old
New
%Chg
Old
New
%Chg
Old
New
%Chg
U.S. Insurance/Life
Neu
Neu
MetLife Inc. (MET)
OW
OW
49.67
55.00
55.00
-
5.83
5.73
-2
6.25
6.25
-
Prudential Financial Inc. (PRU)
OW
OW
101.00
114.00
114.00
-
12.80
12.65
-1
14.00
14.01
0
U.S. Insurance/Non-Life
Neu
Neu
Allstate Corp. (ALL)
OW
OW
101.69
110.00
115.00
5
8.65
8.65
-
10.00
10.00
-
American International Group (AIG)
OW
OW
53.28
60.00
60.00
-
5.38
5.28
-2
5.25
5.25
-
Arch Capital Group Ltd. (ACGL)
OW
OW
37.08
39.00
42.00
8
2.62
2.57
-2
2.80
2.80
-
Arthur J. Gallagher & Co. (AJG)
OW
OW
87.59
97.00
100.00
3
3.88
3.83
-1
4.25
4.25
-
Berkshire Hathaway Inc. (BRK/A / BRK.A)
OW
OW
318350.00
375000.00
375000.00
-
15000.22
14924.20
-1
15981.88
15981.88
-
Berkshire Hathaway Inc. (BRK/B / BRK.B)
OW
OW
213.17
250.00
250.00
-
10.00
9.95
-1
10.65
10.65
-
Chubb Limited (CB)
OW
OW
147.29
167.00
167.00
-
10.65
10.45
-2
11.25
11.25
-
Everest Re Group (RE)
OW
OW
247.18
285.00
285.00
-
25.15
24.40
-3
25.00
25.00
-
Hartford Financial Services Group (HIG)
OW
OW
55.72
62.00
62.00
-
5.25
5.05
-4
5.50
5.50
-
Progressive Corp. (PGR)
OW
OW
79.93
90.00
95.00
6
5.68
5.68
-
6.25
6.25
-
RenaissanceRe Holdings (RNR)
UW
UW
178.01
145.00
165.00
14
13.10
12.60
-4
13.50
13.50
-
The Travelers Companies, Inc. (TRV)
OW
OW
149.52
170.00
170.00
-
11.15
10.75
-4
11.75
11.75
-
Willis Towers Watson Plc (WLTW)
OW
OW
191.54
205.00
220.00
7
10.85
10.85
-
12.25
12.25
-
Source: Barclays Research. Share prices and target prices are shown in the primary listing currency and EPS estimates are shown in the reporting currency.
FY1(E): Current fiscal year estimates by Barclays Research. FY2(E): Next fiscal year estimates by Barclays Research.
Stock Rating: OW: Overweight; EW: Equal Weight; UW: Underweight; RS: Rating Suspended
Industry View: Pos: Positive; Neu: Neutral; Neg: Negative
Barclays | U.S. Insurance
1 July 2019 3
P&C Insurance Estimate and Price Target Changes
Lower 2Q 2019 EPS Estimates on Elevated Catastrophe Losses
We recently lowered our 2Q 19 and 2019 EPS for ALL, which pre-announced elevated
catastrophe losses largely due to tornadoes/wind/hail events mostly in the Midwest.
Today, we lower our 2Q 19 EPS expectations across our remaining covered P&C re/insurers
to reflect our updated estimates for catastrophe losses. We also lowered our 2Q estimate
for AJG due to reflect our updated margin expectation.
FIGURE 1
P&C Insurance 2Q 2019 EPS Estimate Reductions
Source: Barclays Research estimates, Refinitiv
We raise our price targets for several insurers in P&C insurance as summarized in Figure 2
below taking into account sustained overall improvement P&C pricing.
FIGURE 2
Price Target Increase Summary
Source: Barclays Research
2Q - Catastrophe Loss Estimate Operating EPS
Old New 2Q19E FY 2019E
in $mn CR pts in $mn CR pts Old New Consensus
Barclays Est
(% Change)
Barclays Est
(vs. Consensus)
Old New Consensus
Commercial Lines and Reinsurers
CB
$227 3% $337 5% $2.65 $2.45 $2.60 -8% -6% $10.65 $10.45 $10.53
BRK.B
$50 0% $205 2% $2.50 $2.45 $2.65 -2% -7% $10.00 $9.95 $10.43
RE
$171 9% $207 11% $6.25 $5.50 $6.38 -12% -14% $25.15 $24.40 $24.65
TRV
$440 6% $575 8% $2.40 $2.00 $2.36 -17% -15% $11.15 $10.75 $11.11
ACGL
$22 2% $44 3% $0.65 $0.60 $0.66 -8% -10% $2.62 $2.57 $2.66
RNR
$15 2% $38 5% $3.50 $3.00 $3.58 -14% -16% $13.10 $12.60 $13.24
Multiline
AIG
$195 3% $305 5% $1.25 $1.15 $1.13 -8% 2% $5.38 $5.28 $4.90
HIG
$135 5% $225 9% $1.20 $1.00 $1.18 -17% -16% $5.25 $5.05 $5.12
Brokers
AJG
NA NA NA NA $0.70 $0.65 $0.62 -6% 6% $3.88 $3.83 $3.71
Price Target BV ex AOCI 2019E Implied P/B ex AOCI Multiple
Ticker Rating Old New 2019E Old New
Commercial Lines & Reinsurance
ACGL OW $39 $42 $25 1.6x 1.7x
RNR UW $145 $165 $119 1.2x 1.4x
Personal Lines
ALL OW $110 $115 $64 1.7x 1.8x
PGR OW $90 $95 $21 4.4x 4.6x
Price Target Adj. Cash EPS
Ticker Rating Old New 2019E Old New
Insurance Brokers
WLTW OW $205 $220 $10.85 18.9x 20.3x
AJG OW $97 $100 $5.22 18.6x 19.2x
2019E Implied Adj. Cash P/E Multiple
Barclays | U.S. Insurance
1 July 2019 4
FIGURE 3
P&C Focus Areas for 2Q 2019
Company
Focus Area
Commentary
Commercial Lines & Reinsurance
CB
Growth and
Underlying CR
Our 2Q outlook is for 2% growth in total P&C net written premiums. We project an underlying P&C combined
ratio (ex cats and prior year development) of 87.9% versus 88.5% a year ago and 88.1% in the prior quarter.
Share Buybacks
We expect CB to repurchase $375mn of shares in 2Q. Our share buyback expectations are $1.5bn in both FY18
and FY19.
BRK
Bottom Line
We anticipate 2Q 2019 operating EPS (excludes market-to-market investment gains/losses) of $3,681 per A
share ($2.45 per B share), down from $4,190 ($2.79 per B share) a year ago. We project lower y/y earnings for
Insurance, although earnings gains in the BNSF, Berkshire Hathaway Energy, and the Manufacturing, Service,
and Retail segments. We anticipate $2.0bn of earnings in Insurance in 2Q including a $500mn underwriting
gain.
Book Value
Growth
Book value could increase 3.4% q/q in 2Q, driven in part by positive equity market performance. Mark-to-
market investment gains could be approximately $8-9bn pre-tax based on our model.
Excess Cash /
Buybacks
We estimate Berkshire now has at least $80+bn of immediately deployable cash for accretive acquisitions to
supplement organic growth as well as for investments and share buybacks. We anticipate $1.5bn of share
buybacks in 2Q 19, and $6bn annualized in both FY18 and FY19 with upside potential if the company is unable
to deploy excess cash in large acquisitions. We still view a shareholder dividend as unlikely for now.
RE
CEO Succession
Everest Re’s CEO Dom Addesso intends to retire at the end of his current contract term effective YE19. This
transition was largely expected, in our view, as he turns 65. The company has said it would consider both
internal and external successors. We expect this to be a smooth transition for Everest’s business and investors.
Top-Line Growth
Everest’s net written premiums could increase 6% y/y to $1.8bn in 2Q. We estimate RE could achieve gross
written premium growth of x%, including increases in both Insurance (+7% ) and Reinsurance (+5%).
Underlying
Results
We expect Everest to report a 2Q underlying CR (ex-cats and reserve development) of 83.6% compared to
83.5% a year ago and 87.4% in the prior quarter. We anticipate modest favorable prior reserve development of
$11mn (0.6 CR points).
Share Buybacks
Although we view Everest as having sufficient capital, we would expect the company to curtail share buyback
activity in 2019 following large catastrophe losses. We expect $100mn of repurchases in 2020.
TRV
P&C Rates
Commercial P&C renewal rate increases in 1Q 19 improved to +2.2% up from +1.6% in the prior quarter.
Workers’ compensation rate declines remain a drag on the overall result.
Personal Auto
TRV’s agency personal auto insurance PIF has been unchanged since at least 1Q 18. In 1Q 19, the personal
auto underlying CR of 92% meaningfully improved.
The company’s personal auto business is now generating targeted returns, which we believe means it could
focus on returning to growth as long as margins can be maintained. TRV plans to moderate its rate increases in
2019 although rate change is still expected to be positive.
Our outlook is for a 97% combined ratio (96% underlying) in Domestic Agency Auto in 2Q 19.
Share Buybacks
We project $400mn of buybacks in 2Q 19. We project $1.8bn of annual buybacks in both 2019/20.
ACGL
Mortgage
Insurance
In 2Q 19, we expect the combined ratio in Mortgage Insurance could be 31.5% (40.7% underlying) compared
to 25.6% (36.9% underlying) in the prior quarter.
Top-Line Growth
ACGL’s net written premiums could increase 9% y/y in 2Q 19 to $1.4bn including strong growth in Mortgage
Insurance (+17%), Reinsurance (+10%), and Insurance (+10).
RNR
Top-Line Growth
In 2Q, total gross written premiums (which can be lumpy) could increase 26% y/y to $1.2bn including the
acquisition of Tokio Marine Re
Combined Ratio
We expect a 2Q combined ratio of 77.0% (81.9% excluding catastrophe losses and prior year development),
compared to 70.6% (77.7% underlying) a year ago.
M&A
2Q 19 would be the first to include RNR’s completed acquisition of Tokio Marine’s European reinsurance
business for $1.5bn (1x tangible book value) in the form of cash and RNR shares as well as State Farm’s new
$250mn equity investment stake in RNR. Our sense is RNR’s initial accretion expectation could end up being
conservative. The company has initially guided to a run-rate after tax earnings contribution of $100mn from the
acquisition.
Source: Company data, Barclays Research
Barclays | U.S. Insurance
1 July 2019 5
Company
Focus Area
Commentary
Multiline Insurance
HIG
Acquisition of
Navigators
On August 22, 2018, HIG announced its acquisition of specialty underwriter Navigators for $2.1bn in cash.
The acquisition is expected to strengthen HIG’s position in the US commercial middle market and specialty
lines business as well as add complementary specialty and surplus lines insurance capabilities. The acquisition
is expected to be immediately accretive to HIG’s 2019 net income and result in modest book value dilution.
Over time, HIG expects the deal to produce a low double-digit return, driven by revenue growth and modest
expense savings. It is unclear in our view if the acquisition of NAVG could change the potential for HIG to
become a consolidation candidate.
Capital
Management
HIG has announced a new $1bn share buyback authorization with 4Q18 earnings and expects to use
beginning in 2Q 19. We anticipate $500mn of repurchases in 2019 and $800mn in 2020.
2019 Guidance
In terms of 2019 component expectations, the commercial lines combined ratio outlook is 94.5%-96.5%
(91.0%-93.0% underlying). The personal lines combined ratio outlook is 97.5%-99.5% (91.0%-93.0%
underlying). The group benefits core earnings margin outlook is 6.0%-7.0%
P&C Underlying
Combined Ratio
In 2Q, we expect a P&C underlying combined ratio of 91.2%, including a commercial lines underlying
combined ratio of 91.6% and a personal lines underlying combined ratio of 89.9%.
AIG
P&C Combined
Ratio
In 2Q 19, we model an underlying P&C combined ratio of 95.6%, compared to 101% a year ago. The company
has appeared highly confident that AIG should deliver a P&C underwriting profit in ’19. This result is expected
to be achieved by reducing large coverage limits, reducing net exposures after reinsurance protection, limiting
multi-year insurance deals, and reducing expenses.
ROE
Management has sounded confident in its plan to achieve a 10% ROE (ex-DTA/AOCI) by 2021 driven by a
changing business mix, exiting underperforming business lines, and improving performance in P&C lines
already generating an underwriting profit.
Capital
Management
We anticipate $500mn of share buybacks in 2Q 19. We project $1.5bn of annual share buybacks in 2019, and
$2bn in ‘20.
Insurance Brokers
WLTW
Organic Growth
& Margins
Management anticipates FY19 organic growth of ~4% (which we think could be conservative) as well as an
adjusted operating margin of around 20%. We expect 4% organic growth in 2Q 19, below 5% growth in the
prior quarter and above 3% a year ago.
Adjusted Cash
EPS Guidance
The company’s ‘19 guidance includes adjusted cash EPS of $10.60-$10.85, organic revenue growth of ~4%
(5% in FY18), and adjusted operating margin of ~20%. WLTW targets long-term low double-digit EPS growth,
which appears achievable in 2019/20. Over the next three years, the company targets annual free cash flow
growth of more than 15% including in 2019, with momentum building throughout the year.
M&A
WLTW remains upbeat on the prospects for its announced acquisition of Tranzact for $1.2bn in cash, which is
expected to close in 3Q 19 and be accretive to ’19 adjusted earnings. Tranzact is a leading direct-to-consumer
provider that links consumers to insurers, including in the private Medicare space. Tranzact is expected to
generate revenue growth of 25%-30% over the next five years from a base of $260mn in ’18, as well as mid-
20s adjusted operating margins on a standalone basis. WLTW plans on providing updated guidance related to
the transaction in 2Q 19.
AJG
Organic Growth
& Margins
We expect AJG’s Brokerage segment to deliver 5% organic revenue growth in 2Q, slightly below +5.7% in the
prior quarter. The company anticipates FY19 insurance brokerage organic revenue growth to be around 5%
(5.6% in FY18). We expect a 2Q brokerage adjusted EBITDAC margin of 26.9% up from 25.1% a year ago.
M&A
We anticipate Risk management organic growth of 2% in 2Q, down from 4% in the prior quarter. We
anticipate a risk management adjusted EBITDAC margin of 15.1% in 2Q which would be unchanged y/y.
AON
Organic Growth
& Margins
In 2Q 2019, we anticipate Aon could generate 5% organic revenue growth, slightly down from 5% in the prior
quarter. We expect a 2Q adjusted operating margin of 23.5%, up from 22.0% a year ago.
Capital
Management
We model share buybacks of $375mn in 2Q 19, $1.2bn in FY19, and $1.5bn in FY20. Aon targets long-term
double-digit free cash flow growth and expects to release a least $620mn of cash by YE20. Aon has also
characterized the M&A pipeline as the largest in its history.
Expense Savings
Aon now targets $500mn of run-rate expense savings by the end of 2019 (including $140mn in 2019), up
from the previous target of $450mn. The company expects to reinvest a portion of savings in the business.
Source: Company data, Barclays Research
剩余95页未读,继续阅读
资源评论
2201_75761617
- 粉丝: 20
- 资源: 7339
上传资源 快速赚钱
- 我的内容管理 展开
- 我的资源 快来上传第一个资源
- 我的收益 登录查看自己的收益
- 我的积分 登录查看自己的积分
- 我的C币 登录后查看C币余额
- 我的收藏
- 我的下载
- 下载帮助
安全验证
文档复制为VIP权益,开通VIP直接复制
信息提交成功